studies on glp 1 The Many Cardiovascular Benefits of GLP-1 Drugs

Glucagon-like Peptide 1, Glucose-Dependent Insulinotropic Polypeptide, and Glucagon Receptor Agonists in Metabolic Dysfunction-Associated Steatotic Liver Disease: Novel Medication in New Liver Disease Nomenclature

28.53

★★★★☆4.8 (126)

New Research on GLP-1s & Bone Health 🦴 ​A new large-scale study has raised questions about the long-term effects of GLP-1 receptor agonists (like Ozempic and Wegovy). While these medications are revolutionary

25.15

★★★★★4.9 (98)

History of GLP-1 Medications

25.08

★★★★★5.0 (157)

Insights from Specialty Physicians on GLP-1RA Medications Off-Label Use

22.09

★★★★★4.7 (84)

Dietary intake by patients taking GLP-1 and dual GIP/GLP-1 receptor agonists: A narrative review and discussion of research needs

25.79

★★★★★4.9 (203)

Ozempic and other GLP-1 drugs were initially understood as a metabolism breakthrough: medicines that act like hormones to control hunger, blood sugar and weight. But as researchers probe deeper into how the

24.03

★★★★★5.0 (176)

The relationship between the use of GLP-1 receptor agonists and the incidence of respiratory illness: a meta-analysis of randomized controlled trials | Diabetology & Metabolic Syndrome

26.10

★★★★★4.8 (132)